Cargando…

Ovarian Carcinosarcoma and Response to Immunotherapy

Ovarian carcinosarcoma (OCS) is an uncommon and highly aggressive subtype of ovarian cancer. This form of cancer is characterized by limited treatment options and a poor prognosis. In this report, we present a case study of a 64-year-old female diagnosed with stage III OCS, who underwent debulking s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daniyal, Muhammad, Polani, Anamm S, Canary, Marcy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161148/ https://www.ncbi.nlm.nih.gov/pubmed/37153309 http://dx.doi.org/10.7759/cureus.37149

Ejemplares similares

Case Report: Review of CT Findings and Histopathological Characteristics of Primary Liver Carcinosarcoma
por: Huang, Lu, et al.
Publicado: (2021)

Dissecting the Origin of Heterogeneity in Uterine and Ovarian Carcinosarcomas
por: Sertier, Anne-Sophie, et al.
Publicado: (2023)

Response to pembrolizumab in a heavily treated patient with metastatic ovarian carcinosarcoma
por: Zibetti Dal Molin, Graziela, et al.
Publicado: (2018)

Identification of NAD(+) Metabolism-Derived Gene Signatures in Ovarian Cancer Prognosis and Immunotherapy
por: Lin, Liang, et al.
Publicado: (2022)

Prognostic assessment of sarcomatous histologic subtypes of ovarian carcinosarcoma
por: Kim, Hyun Jin, et al.
Publicado: (2017)

A rare and distinct bilateral ovarian tumor: Carcinosarcoma
por: Limaiem, Faten, et al.
Publicado: (2021)

X-box Binding Protein 1 is a Potential Immunotherapy Target in Ovarian Cancer
por: Jiang, Yanhui, et al.
Publicado: (2022)

Immunotherapy response and microenvironment provide biomarkers of immunotherapy options for patients with lung adenocarcinoma
por: Zhan, Xue, et al.
Publicado: (2022)

The gene signature of tertiary lymphoid structures within ovarian cancer predicts the prognosis and immunotherapy benefit
por: Hou, Yue, et al.
Publicado: (2023)

Editorial: The role of immunophenotype in tumor immunotherapy response
por: Qin, Yujuan, et al.
Publicado: (2023)

Borderline mucinous cystic ovarian tumor with mural nodules (carcinosarcoma)
por: Chang, Juei-Shan, et al.
Publicado: (2012)

A rare case of ovarian carcinosarcoma with squamous cell carcinoma
por: Daimon, Atsushi, et al.
Publicado: (2019)

Carcinosarcoma of uterus
por: Tuan, Ho Xuan, et al.
Publicado: (2023)

Carcinosarcoma of the ovary
por: Harris, M A, et al.
Publicado: (2003)

Carcinosarcoma in the Cecum
por: Ryu, Youngjoon, et al.
Publicado: (2012)

Solitary splenic metastasis from ovarian carcinosarcoma: a case report
por: Olsen, Alex B, et al.
Publicado: (2011)

Ovarian Carcinosarcoma: Effects of Cytoreductive Status and Platinum-Based Chemotherapy on Survival
por: Jernigan, Amelia M., et al.
Publicado: (2013)

Primitive ovarian carcinosarcoma: a clinical and radiological analysis of five cases
por: Xu, Qiong, et al.
Publicado: (2020)

Preclinical activity of sacituzumab govitecan (IMMU-132) in uterine and ovarian carcinosarcomas
por: Lopez, Salvatore, et al.
Publicado: (2020)

Establishment and validation of a novel nomogram for survival prediction of ovarian carcinosarcoma
por: Liu, Yi, et al.
Publicado: (2022)

Case Report: Niraparib as Maintenance Therapy in A Patient With Ovarian Carcinosarcoma
por: Zhang, Jie Qing, et al.
Publicado: (2021)

Sjögren-Larsson Syndrome: A Rare Presentation With Developmental Delay
por: J, Srilakshmi K, et al.
Publicado: (2023)

AMH type II receptor and AMH gene polymorphisms are not associated with ovarian reserve, response, or outcomes in ovarian stimulation
por: Cerra, Christian, et al.
Publicado: (2016)

Ovarian Carcinosarcoma and Its Association with Mature Cystic Teratoma and Primary Tubal Carcinoma
por: Rewsuwan, Sunida, et al.
Publicado: (2016)

Prognostic significance of lymph node metastasis and lymphadenectomy in early-stage ovarian carcinosarcoma
por: Wang, Wen-Peng, et al.
Publicado: (2018)

Surgical management of ovarian carcinosarcoma with inferior vena cava extension into the right atrium
por: Merchant, Akeel M, et al.
Publicado: (2020)

Therapeutic Management of Rare Primary Ovarian Neoplasms: Carcinosarcoma, Leiomyosarcoma, Melanoma and Carcinoid
por: Kozłowski, Mateusz, et al.
Publicado: (2021)

Do Not Forget Poly (Adenosine Diphosphate-Ribose) Polymerase Inhibitors in Ovarian Carcinosarcoma
por: Magalhães, Denise, et al.
Publicado: (2022)

Management of a rare ovarian carcinosarcoma: A case report and literature review
por: Fu, Jun
Publicado: (2022)

Primary carcinosarcoma of the gallbladder
por: Park, Sung Bae, et al.
Publicado: (2012)

Primary carcinosarcoma of the spleen
por: Joy, ER, et al.
Publicado: (2012)

Carcinosarcoma of the Maxillary Sinus
por: Moon, Jeong-Ki, et al.
Publicado: (2013)

Carcinosarcoma of the Thyroid Gland
por: Ekici, Mehmet Fatih, et al.
Publicado: (2015)

Pan-cancer analysis of ADAMs: A promising biomarker for prognosis and response to chemotherapy and immunotherapy
por: Ma, Bo, et al.
Publicado: (2023)

Immunotherapy Resistance in Glioblastoma
por: Wang, Elaina J., et al.
Publicado: (2021)

The Role of RAB GTPases and Its Potential in Predicting Immunotherapy Response and Prognosis in Colorectal Cancer
por: Jiang, Xuefei, et al.
Publicado: (2022)

Homologous Recombination Related Signatures Predict Prognosis and Immunotherapy Response in Metastatic Urothelial Carcinoma
por: Li, Pan, et al.
Publicado: (2022)

Ferroptosis-Related Gene Signature Predicts the Prognosis of Skin Cutaneous Melanoma and Response to Immunotherapy
por: Xu, Ziqian, et al.
Publicado: (2021)

Lactate score predicts survival, immune cell infiltration and response to immunotherapy in breast cancer
por: Yin, Ting-Ting, et al.
Publicado: (2022)

A Pyroptosis-Related Signature Predicts Overall Survival and Immunotherapy Responses in Lung Adenocarcinoma
por: Zhu, Kaibin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gm32v7m61775n1ui048evvihgb